Skip Navigation

European Heart Journal 1991 12(3):423-427;
Copyright © 1991 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by DAY, C. P.
Right arrow Articles by CAMPBELL, R. W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DAY, C. P.
Right arrow Articles by CAMPBELL, R. W. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 The European Society of Cardiology

Reduction in QT dispersion by sotalol following myocardial infarction

C. P. DAY, J. M. McCOMB, J. MATTHEWS* and R. W. F. CAMPBELL

Department of Academic Cardiology, Freeman Hospital, Newcastle upon Tyne U.K.
*Department of Medical Statistics, Medical School, University of Newcastle upon Tyne U.K.

Received 27 November 1989; revised 24 April 1990; .

Correspondence and reprint requests to: Dr C. P. Day, Research Fellow, Dept of Medicine, Medical School, University of Newcastle upon Tyne, U.K.

Abstract

Increased dispersion of ventricular recovery time is believed to be a substrate for serious ventricular arrhythmias. Class III antiarrhythmic drugs probably operate by decreasing dispersion through homogeneous prolongation of recovery time. A single surface QT value gives no information on recovery time dispersion but interlead variation in QT may be relevant. QTc dispersion was measured in 67 patients post myocardial infarction randomized to treatment with either sotalol or placebo. QTc dispersion was calculated as the difference between the maximum and minimum QTc in any surface electrocardiogram lead. Both maximum QTc and QTc dispersion varied considerably following infarction but throughout the 6-month follow-up period maximum QTc was significantly greater (P<0.05) and QTc dispersion significantly less (P < 0.05) in patients on sotalol compared with placebo. These findings are in accord with expected changes in ventricular recovery time and provide strong support for the hypothesis that surface electrocardiogram QT variation reflects regional differences in ventricular recovery time

Key Words: Myocardial infarction • sotalol • QT interval • QT dispersion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Respir JHome page
D. Dursunoglu, N. Dursunoglu, H. Evrengul, S. Ozkurt, M. Kilic, F. Fisekci, O. Kuru, and O. Delen
QT interval dispersion in obstructive sleep apnoea syndrome patients without hypertension
Eur. Respir. J., April 1, 2005; 25(4): 677 - 681.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
R. Kumar, M. Fisher, and P. W Macfarlane
Review: Diabetes and the QT interval: time for debate
The British Journal of Diabetes & Vascular Disease, May 1, 2004; 4(3): 146 - 150.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
G. Kabakci, O. Onalan, M. Kemal Batur, A. Yildirir, R. Cagrikul, T. Acil, L. Tokgozoglu, A. Oto, F. Ozmen, and S. Kes
What is the Optimal Evaluation Time of the QT Dispersion After Acute Myocardial Infarction for the Risk Stratification?
Angiology, July 1, 2001; 52(7): 463 - 468.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
K.-M. Yee, S. D. Pringle, and A. D. Struthers
Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1800 - 1807.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
E. Yetkin, K. Senen, M. Ileri, R. Atak, S. Topaloglu, K. Ergun, A. Yanik, I. Tandogan, S. Cehreli, E. Duru, et al.
Diurnal Variation of QT Dispersion in Patients With and Without Coronary Artery Disease
Angiology, May 1, 2001; 52(5): 311 - 316.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
H. Tikiz, T. Terzi, Y. Balbay, A. D. Demir, M. Soylu, T. Keles, and E. Kutuk
QT Dispersion in Single Coronary Artery Disease: Is There a Relation Between QT Dispersion and Diseased Coronary Artery or Lesion Localization?
Angiology, January 1, 2001; 52(1): 43 - 51.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
M. Malik and V. N. Batchvarov
Measurement, interpretation and clinical potential of QT dispersion
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1749 - 1766.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
P. Sahu, P.O. Lim, B.S. Rana, and A.D. Struthers
QT dispersion in medicine: electrophysiological Holy Grail or fool's gold?
QJM, July 1, 2000; 93(7): 425 - 431.
[Full Text] [PDF]


Home page
EuropaceHome page
B. Houltz, B. Darpo, K. Swedberg, P. Blomstrom, H.J.G.M. Crijns, S.M. Jensen, E. Svernhage, and N. Edvardsson
Comparison of QT dispersion during atrial fibrillation and sinus rhythm in the same patients, at normal and prolonged ventricular repolarization
Europace, January 1, 2000; 2(1): 20 - 31.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
S. Paventi, U. Bevilacqua, M. A. Parafati, E. Di Luzio, F. Rossi, P. R. Pelliccioni, and S. Paventi
QT Dispersion and Early Arrhythmic Risk During Acute Myocardial Infarction
Angiology, March 1, 1999; 50(3): 209 - 215.
[Abstract] [PDF]


Home page
HeartHome page
C E Bonnar, A P Davie, L Caruana, L Fenn, S A Ogston, J J V McMurray, and A D Struthers
QT dispersion in patients with chronic heart failure: beta  blockers are associated with a reduction in QT dispersion
Heart, March 1, 1999; 81(3): 297 - 302.
[Abstract] [Full Text]


Home page
EuropaceHome page
L. J. L. M. Jordaens
The clinical value of QTdispersion: new perspectives on the assessment of cardiac repolarization more than 75 years after Bazett's formula
Europace, January 1, 1999; 1(2): 73 - 76.
[PDF]


Home page
HeartHome page
J A Kors and G van Herpen
Measurement error as a source of QT dispersion: a computerised analysis
Heart, November 1, 1998; 80(5): 453 - 458.
[Abstract] [Full Text]


Home page
CirculationHome page
M. C. de Bruyne, A. W. Hoes, J. A. Kors, A. Hofman, J. H. van Bemmel, and D. E. Grobbee
QTc Dispersion Predicts Cardiac Mortality in the Elderly : The Rotterdam Study
Circulation, February 10, 1998; 97(5): 467 - 472.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Gatzoulis, J. A. Till, and A. N. Redington
Depolarization-Repolarization Inhomogeneity After Repair of Tetralogy of Fallot: The Substrate for Malignant Ventricular Tachycardia?
Circulation, January 21, 1997; 95(2): 401 - 404.
[Abstract] [Full Text]


Home page
J CARDIOVASC PHARMACOL THERHome page
P. C. Deedwania
Sotalol Is More Powerful Than Propranolol in Suppressing Complex Ventricular Arrhythmias
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 259 - 272.
[Abstract] [PDF]


Home page
HypertensionHome page
J. Mayet, M. Shahi, K. McGrath, N. R. Poulter, P. S. Sever, R. A. Foale, and S. A. McG. Thom
Left Ventricular Hypertrophy and QT Dispersion in Hypertension
Hypertension, November 1, 1996; 28(5): 791 - 796.
[Abstract] [Full Text]


Home page
BMJHome page
N. J Linker and A. P Fitzpatrick
QTc dispersion and risk of cardiac death in peripheral vascular disease
BMJ, October 26, 1996; 313(7064): 1081c - 1081.
[Full Text]


Home page
CirculationHome page
J.-L. Demolis, C. Funck-Brentano, J. Ropers, M. Ghadanfar, D. J. Nichols, and P. Jaillon
Influence of Dofetilide on QT-Interval Duration and Dispersion at Various Heart Rates During Exercise in Humans
Circulation, October 1, 1996; 94(7): 1592 - 1599.
[Abstract] [Full Text]


Home page
HypertensionHome page
J. S. Perkiomaki, M. J. Ikaheimo, S. M. Pikkujamsa, A. Rantala, M. Lilja, Y. A. Kesaniemi, and H. V. Huikuri
Dispersion of the QT Interval and Autonomic Modulation of Heart Rate in Hypertensive Men With and Without Left Ventricular Hypertrophy
Hypertension, July 1, 1996; 28(1): 16 - 21.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.